Cargando…
Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease Following the ISCHEMIA Trial
Until recently, coronary revascularization with coronary artery bypass grafting or percutaneous coronary intervention has been regarded as the standard choice for stable coronary artery disease (CAD), particularly for patients with a significant burden of ischemia. However, in conjunction with remar...
Autores principales: | Kohsaka, Shun, Ejiri, Kentaro, Takagi, Hidenobu, Watanabe, Ippei, Gatate, Yodo, Fukushima, Kenji, Nakano, Shintaro, Hirai, Taishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982228/ https://www.ncbi.nlm.nih.gov/pubmed/36873769 http://dx.doi.org/10.1016/j.jacasi.2022.10.013 |
Ejemplares similares
-
Ischemia With Nonobstructive Coronary Artery Disease: Concept, Assessment, and Management
por: Hwang, Doyeon, et al.
Publicado: (2023) -
Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
por: Athyros, Vasilios G., et al.
Publicado: (2011) -
Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management
por: Aengevaeren, Vincent L., et al.
Publicado: (2020) -
Successful Bridge-to-Recovery Treatment in a Young Patient with Fulminant Eosinophilic Myocarditis: Roles of a Percutaneous Ventricular Assist Device and Endomyocardial Biopsy
por: Hasegawa-Tamba, Saki, et al.
Publicado: (2019) -
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk
por: Urban, Philip, et al.
Publicado: (2019)